IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Commencement of Phase 2a Sleep Apnoea Clinical Trial, page-14

  1. 1,869 Posts.
    lightbulb Created with Sketch. 1472
    We have perionditis too at Phase 2A. Perhaps all our trials will be Phase 2A. No doubt TMJ and Concussion are coming this quarter after reading our expected expenditure of 300K for R&D for the quarter, which is coincidentally exactly the amount we pay for the 3M worth of trials, and we just got Linneas CBD Oils.

    RespireRX already done a study on dronabinol for sleep apnea and are successful, moving into Phase 3. We are practically doing the same thing, just no one has done it in Aus yet.

    Oy Vey, profit takers and day traders go on then, I'm chilling.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.